- NEW - COVID-19 Vaccination for Pregnant People to Prevent Serious Illness, Deaths, and Adverse Pregnancy Outcomes from COVID-19 - (PDF)
- NEW - Prevention and Management of Pediatric COVID-19 cases, and Reporting of Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 - (PDF)
- NEW - Rapid Increase in Ivermectin Prescriptions and Reports of Severe Illness Associated with Use of Products Containing Ivermectin to Prevent or Treat COVID-19 - (PDF)
- Vaccination to Prevent COVID-19 Outbreaks with Current and Emergent Variants — United States, 2021 - (PDF)
- COVID-19 Whole Genome Sequencing and Other Reporting Requirements - (PDF)
- Reporting of At-Home COVID-19 Testing Results - (PDF)
- COVID-19 Vaccine Breakthrough Cases - (PDF)
- Cases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine - (PDF)
- Continued Vigilance for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 - (PDF)
- COVID-19 Vaccine Breakthrough Cases - (PDF)
- Increase in Fatal Drug Overdoses Across the United States Driven by Synthetic Opioids Before and During the COVID-19 Pandemic - (PDF)
- Options to Shorten Quarantine for COVID-19 - (PDF)
- Reporting of all COVID-19 Laboratory Results - (PDF)
- Health Care Providers and Organizations Can Apply to Receive and Administer Vaccines - (PDF)
- Provider Survey for COVID-19 Vaccine Administration - (PDF)
- Updated Interim Guidance on Testing for SARS-CoV-2 - (PDF)
- Overview of Isolation and Quarantine for COVID-19 - (PDF)
- Reporting of COVID-19 Positive and Negative Laboratory Results - (PDF)
- Interim Guidance on Ending Isolation for COVID-19 Infection and Healthcare Worker Return to Work - (PDF)
- Serious Adverse Health Events Associated with Methanol-based Hand Sanitizers - (PDF)
- Resources to provide to COVID-19 cases and close contacts - (PDF)
- Interim Guidance on testing of close contacts to a confirmed case of COVID-19 - (PDF)
- Detection of Ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis Serogroup Y Isolates, United States, 2019–2020 - (PDF)
- COVID-19 Antibody Testing Guidance - (PDF)
- COVID-19 Testing Considerations for Community Healthcare Providers - (PDF)
- Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19) - (PDF)
- Continuing Hepatitis A Vaccination amid COVID-19 Response (PDF)
- COVID-19 Antibody Testing for Immunity & Return-to-Work Decisions - (PDF)
- Updated Reporting Criteria for 2019 Novel Coronavirus Disease (COVID-19) - (PDF)
- COVID-19 Infection Control Guidance Update & N95 Optimization Strategies - (PDF)
- Updated Guidance for COVID-19 Case Follow-up, Guidelines for Isolation and Quarantine and Cloth Mask Use - (PDF)
- Testing Prioritization for Coronavirus Disease 2019 (COVID-19) Laboratory Testing and Case Reporting - (PDF)
- Latest Guidance on the Discontinuation of Isolation and Quarantine & DHEC Guidance on the Management of Healthcare Personnel (HCPs) who are positive for COVID-19 or exposed to COVID-19 patients - (PDF)
- Updated DHEC and CDC Guidance on COVID-19 Patient Testing & Global / River Cruises (COVID-19) - (PDF)
- View Previous Health Alert Network (HAN) Updates